Attention Deficit Disorder With Hyperactivity Clinical Trial
Official title:
Determinants of Treatment Response to State-of-the-art Interventions for Attention Deficits: Child Temperament, Cognitive Profiles and Family Dynamics
Verified date | November 2023 |
Source | University of Crete |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main aim of this study is the development and implementation of a multimodal intervention program consisting of parent training and child training which utilizes the potentials of immersive virtual reality technology (iVR) in order to test its effectiveness for children with attention deficits.
Status | Completed |
Enrollment | 16 |
Est. completion date | November 30, 2022 |
Est. primary completion date | November 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 12 Years |
Eligibility | Inclusion Criteria: - Participants 9-12 years old and their parents - ADHD diagnosis (by the approved body of Ministry of Health) - Greek speaking participants (child and parents) - Full Scale IQ > 80 (WISC-V) for child - Naïve drug treatment for ADHD - Participants able to comply with all testing and study requirements Exclusion Criteria: - Treatment with psychostimulants or other psychotropic drugs - Children who received intervention based on CBT or parents who attended other behavior parent training programs - History of comorbid neurological disorders, seizure disorder, autism spectrum disorders, psychosis, or severe dysregulation disorders that may interfere with study participation or use of virtual reality equipment - Participants presenting a hearing or vision impairment that does not allow the tasks to be performed with the use virtual reality equipment - Intellectual disability or WISC-V full scale IQ < 78 (1.5 standard deviations (SD) below mean) - Non-Greek speaking child or parent - Parents or children who refuse to give written consent for their participation in the study |
Country | Name | City | State |
---|---|---|---|
Greece | University of Crete, Department of Psychology | Rethymnon |
Lead Sponsor | Collaborator |
---|---|
University of Crete |
Greece,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ADHD Rating Scale-IV (ADHD-RS-IV) - Greek | ADHD Rating Scale-IV (Greek version, parent report) is a clinician-administered questionnaire completed by the child's parents. The scale consists of 18 questions that assess inattention (9 items) and hyperactivity/impulsivity (9 items). The total score is obtained by adding the raw scores of Inattention subscale and Hyperactivity/impulsivity subscale. Each item is rated on a 4-point Likert scale (0=Never or Rarely, 1=Sometimes, 2=Often, 3=Very Often) with total scores ranging from 0-54, while inattention subscale score and hyperactivity/impulsivity subscale score range from 0-27 each. A higher score indicates more severe ADHD symptoms.
Changes in scores of Inattention subscale, Hyperactivity/Impulsivity subscale and Total Score will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Primary | Attention Network Task | Attention Network Task (ANT child version) is a computerized task that was developed to measure the three networks of attention in children as described by Posner and colleagues, namely the alerting network, the orienting network and the executive control network.
The scores for each network are obtained by reaction time subtractions of different stimulus combinations (cues, congruent conditions, incongruent conditions). Changes in scores of alerting network, orienting network and executive control network will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Primary | Go/ No-Go Task | Go/No-Go task is a computerized task that was developed to measure attention and response inhibition. The task was developed by the research team in accordance with Conner's CPT-III task and the participant responds to certain stimuli (Go-trials) and withhold response to other stimuli (No-Go trials). There are 6 blocks of 60 trials (80% go-trials, 20% no-go trials) and there are four scores obtained from participants' responses: 1) Correct hits rate, 2) Omission error rate (do not respond in a target, inattention), 3) Commission error rate (response on a no-go trial, impulsivity) and 4) Reaction time of response on a go-trial (slower RT shows inattention).
Changes in: 1) average correct hits rate, 2) average number of omission errors, 3) average number of commission errors and 4) reaction time variability will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Primary | Psychosocial Adjustment Test (Child report) | Psychosocial Adjustment Test is an assessment tool for the timely detection of children's skills or deficiencies in the social and emotional areas of their lives, in school adaptation as well as for the detection of difficulties in intrapersonal or interpersonal adaptation. It consists of 115 questions in a 5-point Likert scale (1=Not at all, 2=A little, 3=Moderate, 4=Very, 5=Too much) that yield five different factors: 1) Social adequacy, 2) School adequacy, 3) Emotional adequacy, 4) Self-perception and 5) Behavioral problems.
Changes in 1) Social adequacy, 2) Emotional adequacy and 3) Behavioral problems will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Secondary | Working memory (WISC-V) | Working Memory Index (WISC-V) measures a child's ability to register, maintain and manipulate visual and auditory information in mind. Working Memory Index from WISC-V consists of two subscales: Digit Span and Picture Span.
Changes in Working Memory Index results will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Secondary | Tower of Rethymnon (similar to Tower of Hanoi or Tower of London) | Tower of Rethymnon is a subtest included in the Detection and Evaluation Tool for Executive Functions and it is an adaptation of the Tower of London. This test evaluates the ability to plan, to use cognitive control and to solve problems in non-verbal contexts.
Changes in Tower of Rethymnon results will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Secondary | Parenting Stress Index-Short Form (PSI-SF) | Parenting Stress Index-Short Form (PSI-SF) is a parent-report questionnaire that evaluates parenting stress, which is a variable affected by child's characteristics, parent's characteristics and by the situations surrounding their relationship. It consists of 36 items and results in five subcategories of parenting stress: 1) Parental Distress Score, 2) Parent-Child Dysfunctional Interaction Score, 3) Difficult Child Score, 4) Total Stress Score and 4) Defensive Responding Score.
Changes in the above five scores will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks | |
Secondary | Parenting Sense of Competence Scale (PSOC) | Parenting Sense of Competence Scale (PSOC) is a parent-report questionnaire that evaluates the parents' sense and perception regarding their parental ability and adequacy. It consists of 17 items and results in a Total PSOC Score. Higher score indicates greater sense of parental adequacy.
Changes in Total PSOC Score will be evaluated before, during and after the intervention as well as at a follow-up assessment (3-4 months after the end of the intervention program). |
8-16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |